LOGO
LOGO

Article Search

Discover the power of RTTNews website's advanced search page, designed for seamless Article retrieval by Company Name, Stock Symbol, and other criteria.
Stay updated with the Latest News on specific Companies, Financial Insights, and Market Trends. We Ensure you to get the most relevant information instantly.

Symbol  
Company  
Currency Symbol   eg (EUR/USD)
Keyword  
  • Argenx: FDA Accepts For Priority Review A SBLA For VYVGART Hytrulo In Chronic Inflammatory Demyelinating Polyneuropathy 2/20/2024 1:08:17 AM
  • Argenx Announces Approval Of VYVDURA Injection For Subcutaneous Use In Japan For Generalized Myasthenia Gravis 1/18/2024 1:08:44 AM
  • Argenx Announces Q4 Preliminary Global Net VYVGART Revenues Of About $374 Mln 1/8/2024 1:13:36 AM
  • Wedbush Reiterates argenx SE (ARGX) At Outperform With $131 Up From $130 Price Target 12/4/2018 7:49:18 AM
  • Wedbush Reiterates argenx SE (ARGX) At Outperform With $130 Up From $125 Price Target 11/5/2018 6:53:28 AM
  • Wedbush Reiterates argenx SE (ARGX) At Outperform With $125 Up From $121 Price Target 9/20/2018 6:43:14 AM
  • Wedbush Reiterates argenx SE (ARGX) At Outperform With $121 Up From $114 Price Target 9/18/2018 6:38:23 AM
  • Wedbush Is Lowering argenx SE (ARGX) FY18 Rev. Estimate To 14.2 M From 16.1 M 5/10/2018 11:56:26 AM
  • Wedbush Is Lowering argenx SE (ARGX) Q4 18 Rev. Estimate To 2.5 M From 3.0 M 5/10/2018 11:56:11 AM
  • Wedbush Is Lowering argenx SE (ARGX) Q3 18 Rev. Estimate To 2.4 M From 2.9 M 5/10/2018 11:55:59 AM
  • Wedbush Is Lowering argenx SE (ARGX) Q2 18 Rev. Estimate To 2.4 M From 2.9 M 5/10/2018 11:55:49 AM
  • Wedbush Is Cutting argenx SE (ARGX) FY18 Estimate To -2.61 From -2.55 5/10/2018 11:55:01 AM
Copyright © 2026 RTTNews. All rights reserved. By using this site, you agree to the Terms of Service. About Us   |   Contact Us   |   Privacy   |   Sitemap